The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2016

Filed:

Feb. 27, 2009
Applicants:

Cristina Carreño Serraïma, Barcelona, ES;

Wim Van Den Nest, Vilanova I La Geltru-Barcelona, ES;

Juan Cebri{dot Over (A)}n Puche, Barcelona, ES;

Nuria Almiñana Domenech, Barcelona, ES;

Antonio Ferrer Montiel, Alicante, ES;

Nuria Garcia Sanz, El Campello, ES;

Inventors:

Cristina Carreño Serraïma, Barcelona, ES;

Wim Van Den Nest, Vilanova I La Geltru-Barcelona, ES;

Juan Cebri{dot over (a)}n Puche, Barcelona, ES;

Nuria Almiñana Domenech, Barcelona, ES;

Antonio Ferrer Montiel, Alicante, ES;

Nuria Garcia Sanz, El Campello, ES;

Assignee:

Lipotec, S.A., Gava, Barcelona, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/81 (2006.01); A61K 8/64 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/127 (2006.01); A61Q 7/00 (2006.01); A61Q 19/06 (2006.01); A61Q 19/08 (2006.01); C07K 5/11 (2006.01); A61K 38/00 (2006.01); A61Q 5/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/8146 (2013.01); A61K 8/64 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/127 (2013.01); A61Q 7/00 (2013.01); A61Q 19/06 (2013.01); A61Q 19/08 (2013.01); C07K 5/1019 (2013.01); A61K 38/00 (2013.01); A61Q 5/00 (2013.01);
Abstract

Peptides of general formula (I): RAA-AA-AA-AA-Rstereoisomers thereof, mixtures thereof or the cosmetically or pharmaceutically acceptable salts thereof, a method for obtaining them, cosmetic or pharmaceutical compositions containing them, and their use for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, mucosae and/or scalp resulting from matrix metalloproteinases (MMP) overexpression or an increase in the MMP activity.


Find Patent Forward Citations

Loading…